Which Tarbell fans are making a difference right now?
Pioneering journalism that informs, galvanizes and changes America.
Tarbell uncovers how powerful people and companies use their influence to shape a system that works for them, not you. We highlight solutions to pressing problems. Our fiercely independent, unbiased news inspires people in all 50 U.S. states to take action.
We understand there are stories that matter to all Americans. We believe there’s journalism that can inspire people to see how much we agree. We know people want actionable, evidence-based solutions.
Have a question or tip for a story? Email questions@tarbell.org. Want to work with us? Email hello@tarbell.org.
Tarbell is a proud member of the Institute for Nonprofit News. Sign up here to receive weekly emails from Tarbell.
On this episode, Wendell and Joey discuss health care reform, Rural America and the state of health care journalism with past president of the Association of Health Care Journalists and Tarbell.org contributor, Trudy Lieberman.
SEASON 2 COMING SOON
UNDER THE INFLUENCE
Under the influence is Tarbell’s weekly roundup of stories and ideas related to how special interests operate in America.
– JOIN THE NEWSLETTER TODAY –
Fighting a pharmacy benefit manager: A woman’s doctor wanted her to take one medication. CVS Caremark wanted her to take the one that would threaten her life.
Dr. Kantarjian, chair of the Department of Leukemia at the University of Texas MD Anderson Center, explores the actions the US government can take if it is serious on lowering the sky-high cost of pharmaceuticals.
While PBMs are consolidating and increasing their power, it’s critical to become an informed “consumer” of your prescription fulfillment service.
UNDER THE INFLUENCE
Under the Influence is Tarbell’s weekly roundup of stories and ideas related to how special interests operate in America.
– JOIN THE NEWSLETTER TODAY –
UNDER THE INFLUENCE
Under the Influence is Tarbell’s weekly roundup of stories and ideas related to how special interests operate in America.
– JOIN THE NEWSLETTER TODAY –
If you are wondering why a doctor won’t consider prescribing a cheaper prescription drug, consider exploring Medicare’s database of pharma payments to physicians.
Although not all Medicare Advantage plans are alike, people with complex conditions are often hard-pressed to see the doctors they want to see and get the care they need when enrolled in a commercial Medicare Advantage plan.
An Appalachian community physician explains why all the hospitals in his region fall under one system, and queries the degree that these mergers benefit rural patients.
Critics feared the worst on March 14, but under pressure from activists and Tarbell reporting, an Oregon panel has tabled a vote on a cut-off that could raise the risk of suicide nearly 300%.
How health insurance cash forms opinions on Medicare for All.
Some seniors enrolled in Medicare have a three-month period where they can consider switching their plans, so Trudy Lieberman considers whether it’s worth making the change.
Some states are once again offering insurance across trade organizations or business groups, but will the revamped program have the same old flaws?
A two month coma, a misdiagnosis and a $3 million bill.
Big Pharma dresses wolves in sheep’s clothing to keep drug prices high. Don’t be deceived. Learn how to sniff them out.
“The crooks already know these tricks; honest men must learn them in self-defense.”
My former colleagues undoubtedly were cheering when they heard Sen. Michael Bennet (D-Colo.) come to the defense of private health insurers and trash the idea of improving and expanding Medicare to cover all Americans.
“Open enrollment is over and the flood of advertisements for Medicare Advantage plans has ended for another year. I’m happy to report that, once again, I’ve managed to avoid signing up for one of those plans.”
Veteran government and corporate watchdog will lead Tarbell.org reporting.
Without the protections in the Affordable Care Act, many would find themselves back in the “bad old days.”
What we learned: Addressing the problem will require the private and public sectors to agree on solutions.
What you can do: Call Congress, the FDA and the White House.